Clinuvel Pharmaceuticals Limited (ASX:CUV)

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Biopharmaceutical	88.18M
Biopharmaceutical Growth	12.59%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Europe & United States	81.48M
Europe & United States Growth	12.73%
Switzerland, Others	6.70M
Switzerland, Others Growth	10.88%